These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 8627675)
1. Identification and mapping of functional domains on human T-cell lymphotropic virus type 1 envelope proteins by using synthetic peptides. Sagara Y; Inoue Y; Shiraki H; Jinno A; Hoshino H; Maeda Y J Virol; 1996 Mar; 70(3):1564-9. PubMed ID: 8627675 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of cell-free human T-cell leukemia virus type 1 infection at a postbinding step by the synthetic peptide derived from an ectodomain of the gp21 transmembrane glycoprotein. Jinno A; Haraguchi Y; Shiraki H; Hoshino H J Virol; 1999 Nov; 73(11):9683-9. PubMed ID: 10516085 [TBL] [Abstract][Full Text] [Related]
3. Mapping of immunogenic regions of human T cell leukemia virus type I (HTLV-I) gp46 and gp21 envelope glycoproteins with env-encoded synthetic peptides and a monoclonal antibody to gp46. Palker TJ; Tanner ME; Scearce RM; Streilein RD; Clark ME; Haynes BF J Immunol; 1989 Feb; 142(3):971-8. PubMed ID: 2563272 [TBL] [Abstract][Full Text] [Related]
4. Trypsin-sensitive and -resistant components in human T-cell membranes required for syncytium formation by human T-cell lymphotropic virus type 1-bearing cells. Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y J Virol; 1997 Jan; 71(1):601-7. PubMed ID: 8985389 [TBL] [Abstract][Full Text] [Related]
5. Identification of a novel neutralization epitope on envelope gp46 antigen of human T-cell-leukemia virus-type-II (HTLV-II). Tanaka Y; Tanaka R; Hoshino H Int J Cancer; 1994 Dec; 59(5):655-60. PubMed ID: 7525496 [TBL] [Abstract][Full Text] [Related]
6. Molecular cloning, expression, and biological characterization of an HTLV-II envelope glycoprotein: HIV-1 expression is permissive for HTLV-II-induced cell fusion. Wang B; Agadjanyan MG; Srikantan V; Ugen KE; Hall W; Kaplan MH; Dang K; Williams WV; Weiner DB AIDS Res Hum Retroviruses; 1993 Sep; 9(9):849-60. PubMed ID: 8257634 [TBL] [Abstract][Full Text] [Related]
7. Phosphatidylglycerol participates in syncytium formation induced by HTLV type 1-bearing cells. Sagara Y; Inoue Y; Kojima E; Ishida C; Shiraki H; Maeda Y AIDS Res Hum Retroviruses; 2001 Jan; 17(2):125-35. PubMed ID: 11177392 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel neutralization-inducing regions of the human T cell lymphotropic virus type I envelope glycoproteins with human HTLV-I-seropositive sera. Desgranges C; Souche S; Vernant JC; Smadja D; Vahlne A; Horal P AIDS Res Hum Retroviruses; 1994 Feb; 10(2):163-73. PubMed ID: 8198868 [TBL] [Abstract][Full Text] [Related]
9. Mapping of homologous, amino-terminal neutralizing regions of human T-cell lymphotropic virus type I and II gp46 envelope glycoproteins. Palker TJ; Riggs ER; Spragion DE; Muir AJ; Scearce RM; Randall RR; McAdams MW; McKnight A; Clapham PR; Weiss RA J Virol; 1992 Oct; 66(10):5879-89. PubMed ID: 1326649 [TBL] [Abstract][Full Text] [Related]
10. Heat shock cognate protein 70 is a cell fusion-enhancing factor but not an entry factor for human T-cell lymphotropic virus type I. Fang D; Haraguchi Y; Jinno A; Soda Y; Shimizu N; Hoshino H Biochem Biophys Res Commun; 1999 Aug; 261(2):357-63. PubMed ID: 10425190 [TBL] [Abstract][Full Text] [Related]
11. HTLV type 1 envelope glycoprotein gp46 evokes necrosis by binding to receptor complex. Sagara Y; Inoue Y; Kojima E; Shiraki H; Maeda Y AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1701-4. PubMed ID: 11080813 [TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type 1 envelope-mediated syncytium formation can be activated in resistant Mammalian cell lines by a carboxy-terminal truncation of the envelope cytoplasmic domain. Kim FJ; Manel N; Boublik Y; Battini JL; Sitbon M J Virol; 2003 Jan; 77(2):963-9. PubMed ID: 12502812 [TBL] [Abstract][Full Text] [Related]
13. Identification of new epitopes recognized by human monoclonal antibodies with neutralizing and antibody-dependent cellular cytotoxicity activities specific for human T cell leukemia virus type 1. Kuroki M; Nakamura M; Itoyama Y; Tanaka Y; Shiraki H; Baba E; Esaki T; Tatsumoto T; Nagafuchi S; Nakano S J Immunol; 1992 Aug; 149(3):940-8. PubMed ID: 1378869 [TBL] [Abstract][Full Text] [Related]
14. Multiple neutralizing B-cell epitopes of human T-cell leukemia virus type 1 (HTLV-1) identified by human monoclonal antibodies. A basis for the design of an HTLV-1 peptide vaccine. Baba E; Nakamura M; Tanaka Y; Kuroki M; Itoyama Y; Nakano S; Niho Y J Immunol; 1993 Jul; 151(2):1013-24. PubMed ID: 7687611 [TBL] [Abstract][Full Text] [Related]
15. Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Palker TJ; Clark ME; Langlois AJ; Matthews TJ; Weinhold KJ; Randall RR; Bolognesi DP; Haynes BF Proc Natl Acad Sci U S A; 1988 Mar; 85(6):1932-6. PubMed ID: 2450351 [TBL] [Abstract][Full Text] [Related]
16. Identification of a neutralization epitope on the envelope gp46 antigen of human T cell leukemia virus type I and induction of neutralizing antibody by peptide immunization. Tanaka Y; Zeng L; Shiraki H; Shida H; Tozawa H J Immunol; 1991 Jul; 147(1):354-60. PubMed ID: 1711082 [TBL] [Abstract][Full Text] [Related]
17. Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. Ruegg CL; Monell CR; Strand M J Virol; 1989 Aug; 63(8):3250-6. PubMed ID: 2746730 [TBL] [Abstract][Full Text] [Related]
18. Mechanism of inhibitory effect of dextran sulfate and heparin on human T-cell lymphotropic virus type I (HTLV-I)-induced syncytium formation in vitro: role of cell-to-cell contact. Ida H; Kurata A; Eguchi K; Yamashita I; Nakashima M; Sakai M; Kawabe Y; Nakamura T; Nagataki S Antiviral Res; 1994 Feb; 23(2):143-59. PubMed ID: 7908510 [TBL] [Abstract][Full Text] [Related]
19. Identification of type-specific linear epitopes in the glycoproteins gp46 and gp21 of human T-cell leukemia viruses type I and type II using synthetic peptides. Horal P; Hall WW; Svennerholm B; Lycke J; Jeansson S; Rymo L; Kaplan MH; Vahlne A Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5754-8. PubMed ID: 1712105 [TBL] [Abstract][Full Text] [Related]
20. 71-kilodalton heat shock cognate protein acts as a cellular receptor for syncytium formation induced by human T-cell lymphotropic virus type 1. Sagara Y; Ishida C; Inoue Y; Shiraki H; Maeda Y J Virol; 1998 Jan; 72(1):535-41. PubMed ID: 9420256 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]